Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 2/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17387416 | 0.85 | MMP1 (0.33) | MMP1MMP2CA1CA2CA12 | |
| SCHEMBL1810893 | 0.83 | MMP1 (0.32) | MMP1MMP2CA1CA2CA12 | |
| SCHEMBL1038146 | 0.83 | MMP1 (0.32) | MMP1MMP2CA1CA2CA12 | |
| SCHEMBL7154902 | 0.82 | KDM4E (0.31) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL305474 | 0.82 | CAD (0.36) | MMP1MMP2CA1CA2CA12 | |
| SCHEMBL15453368 | 0.82 | MMP1 (0.31) | MMP1MMP2CA1CA2KDM4E | |
| SCHEMBL135381 | 0.81 | TGFBR1 (0.41) | ALDH1A1 | |
| SCHEMBL3640237 | 0.80 | CAD (0.35) | MMP1MMP2CA1CA2CA12 | |
| SCHEMBL3402750 | 0.79 | SMN1; SMN2 (0.36) | KDM4ESMN1; SMN2ALDH1A1LMNAMGAM | |
| SCHEMBL2494021 | 0.77 | TSHR (0.44) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12469872-B2 | Fluoropolymer hybrid composite | SYENSQO SA (BE) | 2025-11-11 | — | — | US | claimed |
| US-12391819-B2 | Fluoropolymer-based hybrid organic/inorganic composites | SYENSQO SA (BE) | 2025-08-19 | — | — | US | claimed |
| EP-3724939-B1 | FLUOROPOLYMER MEMBRANE FOR ELECTROCHEMICAL DEVICES | SYENSQO SA (BE) | 2025-08-13 | — | — | EP | claimed |
| US-11975091-B2 | Composition for enhancing protein strength | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2024-05-07 | — | — | US | claimed |
| CN-111466042-B | Fluoropolymer membranes for electrochemical devices | 索尔维公司 | 2024-03-29 | — | — | CN | claimed |
| CN-117701240-A | Organopolysiloxane composition with good shape retention and preparation method thereof | 烟台德邦科技股份有限公司 | 2024-03-15 | — | — | CN | claimed |
| CN-116903259-A | Hybrid organic/inorganic composite materials based on fluoropolymers | 索尔维特殊聚合物意大利有限公司 | 2023-10-20 | — | — | CN | claimed |
| US-11702491-B2 | Membrane including fluoropolymer hybrid organic/inorganic composite, and electrochemical device having the same | SOLVAY SA (BE) | 2023-07-18 | — | — | US | claimed |
| EP-3724140-B1 | FLUOROPOLYMER-BASED HYBRID ORGANIC/INORGANIC COMPOSITES | SOLVAY SPECIALTY POLYMERS IT (IT) | 2022-03-09 | — | — | EP | claimed |
| US-20210401714-A1 | Composition For Enhancing Protein Strength | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2021-12-30 | — | — | US | claimed |
| US-20160282341-A1 | PLASMONIC BIOSENSORS WITH BUILT-IN ARTIFICIAL ANTIBODIES | WASHINGTON UNIVERSITY IN ST. LOUIS | 2016-09-29 | — | — | US | claimed |
| US-20150253317-A1 | LABEL-FREE DETECTION OF RENAL CANCER | WASHINGTON UNIVERSITY | 2015-09-10 | — | — | US | claimed |
| WO-2015058046-A1 | PLASMONIC BIOSENSORS WITH BUILT-IN ARTIFICIAL ANTIBODIES | WASHINGTON UNIVERSITY (US) | 2015-04-23 | — | — | WO | claimed |
| EP-2580294-B1 | PVDF COATING COMPOSITIONS | SOLVAY SOLEXIS SPA (IT) | 2015-02-25 | — | — | EP | claimed |
| EP-2580294-A1 | PVDF COATING COMPOSITIONS | Solvay Solexis S.p.A. (IT) | 2013-04-17 | — | — | EP | claimed |
| US-20130090417-A1 | PVDF coating compositions | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2013-04-11 | — | — | US | claimed |
| WO-2011157657-A1 | PVDF COATING COMPOSITIONS | SOLVAY SOLEXIS S.P.A. (IT) | 2011-12-22 | — | — | WO | claimed |
| US-7921911-B2 | Surface-modifying agents for wettability modification | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2011-04-12 | — | — | US | claimed |
| WO-2010076745-A1 | SURFACE-MODIFYING AGENTS FOR WETTABILITY MODIFICATION | SCHLUMBERGER CANADA LIMITED (CA) | 2010-07-08 | — | — | WO | claimed |
| US-20100163234-A1 | Surface-Modifying Agents for Wettability Modification | SCHLUMBERGER TECHNOLOGY CORPORATION | 2010-07-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210401714-A1 | Composition For Enhancing Protein Strength | CUTA, S100A4, S100A8 | MMP1 891/4885MMP2 1112/4885CA1 2996/4885 |
| US-11975091-B2 | Composition for enhancing protein strength | CUTA, S100A4, S100A8 | MMP1 891/4885MMP2 1112/4885CA1 2996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.